Wuhan Haite Biopharmaceutical Co., Ltd. (hereinafter referred to as "the Company" or "Haite Bio") is a company listed on the Growth Enterprise Market of Shenzhen Stock Exchange. The main business is the production and sales of bioengineering products and freeze-dried powder injections; The import and export business of our products and technologies. At present, the company has 25 production numbers of biological products and chemicals.
The company park covers an area of138,000 square meters, with an existing building area of 6 1 10,000 square meters. It has a production workshop of148,000 square meters that meets the national GMP standards, with complete facilities and first-class equipment. And the corresponding drug quality management system, establish and improve the quality management department, carry out drug production and total quality management in strict accordance with GMP requirements, in order to realize the company's quality policy and optimize product quality.
Scientific research platform:
The company is a high-tech enterprise in Hubei Province. There are postdoctoral mobile workstations approved by Ministry of Human Resources and Social Security, "Hubei Rare Disease Drug Engineering Technology Research Center" and "Hubei High-tech Innovation Enterprise" approved by the Provincial Science and Technology Department, and five basic technology work platforms and pilot bases have been established to promote the industrialization and efficient transformation of related achievements to the market.